Cornelison, R.; Biswas, K.; Llaneza, D.C.; Harris, A.R.; Sosale, N.G.; Lazzara, M.J.; Landen, C.N.
CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer. Cancers 2021, 13, 5056.
https://doi.org/10.3390/cancers13205056
AMA Style
Cornelison R, Biswas K, Llaneza DC, Harris AR, Sosale NG, Lazzara MJ, Landen CN.
CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer. Cancers. 2021; 13(20):5056.
https://doi.org/10.3390/cancers13205056
Chicago/Turabian Style
Cornelison, Robert, Kuntal Biswas, Danielle C. Llaneza, Alexandra R. Harris, Nisha G. Sosale, Matthew J. Lazzara, and Charles N. Landen.
2021. "CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer" Cancers 13, no. 20: 5056.
https://doi.org/10.3390/cancers13205056
APA Style
Cornelison, R., Biswas, K., Llaneza, D. C., Harris, A. R., Sosale, N. G., Lazzara, M. J., & Landen, C. N.
(2021). CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer. Cancers, 13(20), 5056.
https://doi.org/10.3390/cancers13205056